The US Food and Drug Administration (FDA) expanded approval of an automated insulin delivery system to include its use for people with type 2 diabetes aged 18 years or older. The software, marketed as the Insulet SmartAdjust, works with an automated insulin pump and a glucose sensor to adjust insulin delivery every 5 minutes. The FDA previously authorized it for those with type 1 diabetes aged 2 years or older.
